Related Experiment Video

Updated: Jun 25, 2025

Generation of a Mouse Artificial Decidualization Model with Ovariectomy for Endometrial Decidualization Research
06:38

Generation of a Mouse Artificial Decidualization Model with Ovariectomy for Endometrial Decidualization Research

Published on: July 27, 2022

5.3K

NEK2 promotes the development of ovarian endometriosis and impairs decidualization by phosphorylating FOXO1

Mengxue Wang1,2, Fangyuan Sun1,2, Shucai Zhang3

  • 1Department of Reproductive Medicine, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong Province, P.R. China.

Cellular and Molecular Life Sciences : CMLS
|May 25, 2024
PubMed

Insights

This study reveals NEK2 kinase promotes endometriosis by impairing decidualization via FOXO1 phosphorylation. Inhibiting NEK2 offers a potential therapeutic strategy for endometriosis and infertility.

Area of Science:

  • Gynecology
  • Cell Biology
  • Reproductive Medicine

Background:

  • Ovarian endometriosis is a common condition linked to infertility.
  • Defective endometrial decidualization in endometriosis impairs embryo implantation and early pregnancy.
  • The precise mechanisms driving endometriosis and its associated decidual defects remain largely unknown.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying endometriosis development and defective decidualization.
  • To investigate the role of NEK2 in endometriosis and its impact on endometrial receptivity.
  • To identify potential therapeutic targets for endometriosis-associated infertility.

Main Methods:

  • Assessed NEK2 expression in endometrial tissues from endometriosis patients.
  • Investigated the interaction between NEK2 and FOXO1, including phosphorylation at Ser184.
  • Utilized mouse models to evaluate the effects of NEK2 inhibition (using INH1) on endometriosis lesions and decidualization.

Main Results:

  • NEK2 expression is elevated in both ectopic and eutopic endometrium of endometriosis patients.
  • NEK2 phosphorylates FOXO1 at Ser184, reducing its stability and promoting cell proliferation, migration, and invasion.
  • NEK2 inhibition by INH1 suppressed ectopic lesion growth and enhanced decidualization in mouse models.

Conclusions:

  • NEK2 plays a critical role in endometriosis pathogenesis and impaired decidualization through FOXO1 phosphorylation.
  • Targeting NEK2 represents a promising therapeutic avenue for treating endometriosis and improving fertility outcomes.
Keywords:
DecidualizationEndometriosisFOXO1NEK2

More Related Videos

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.7K
Isolation of Human Endometrial Stromal Cells for In Vitro Decidualization14:55

Isolation of Human Endometrial Stromal Cells for In Vitro Decidualization

Published on: September 1, 2018

10.2K

Related Concept Videos

Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.1K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
474
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
345